Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis-Reference-Cited by-同舟云学术

Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis

Published:2015-09 Issue: Volume:63 Page:47-58
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Nezos Adrianos,Gravani Fotini,Tassidou Anna,Kapsogeorgou Efstathia K.,Voulgarelis Michael,Koutsilieris Michael,Crow Mary K.,Mavragani Clio P.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference57 articles.

1. Sjogren's syndrome;Mavragani;Annu. Rev. Pathol.,2014

2. The risk of lymphoma development in autoimmune diseases: a meta-analysis;Zintzaras;Arch. Intern. Med.,2005

3. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome;Ioannidis;Arthritis Rheum.,2002

4. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: Correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development

5. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome;Theander;Ann. Rheum. Dis.,2011

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GZMK+CD8+ T cells Target A Specific Acinar Cell Type in Sjögren’s Disease;2024-07-11

2. Update on the pathophysiology and treatment of primary Sjögren syndrome;Nature Reviews Rheumatology;2024-07-09

3. Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: Implications for progressive multifocal leukoencephalopathy risk stratification;Journal of the Neurological Sciences;2024-06

4. Emerging biologic frontiers for Sjogren’s syndrome: Unveiling novel approaches with emphasis on extra glandular pathology;Frontiers in Pharmacology;2024-05-17

5. Transcriptomic Profiling of Peripheral B Cells in Antibody Positive Sjogren’s Patients Reveals Interferon Signature;Genes;2024-05-15